Back to TRDA

Lynx1 Capital Management LP → TRDA

Lynx1 Capital Management LP TRDA Position History

Entrada Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$1.8M
Q3 2026
Peak value
$2.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$531K
Q1 2026$2.7M
Q2 2026$1.3M
Q2 2026$1.3M
Q3 2026$1.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.8M278.6K——
Q2 2026$1.3M178.6K——
Q2 2026$1.3M178.6K——
Q1 2026$2.7M211.7K——
Q4 2025$531K51.7K——

Other funds holding TRDA

Other Lynx1 Capital Management LP positions

GHRS

GH RESEARCH PLC

$356.5M
GHRS

GH RESEARCH PLC

$311.4M
STOK

STOKE THERAPEUTICS INC

$171.5M
CGEM

CULLINAN THERAPEUTICS INC

$163.2M
CGEM

CULLINAN THERAPEUTICS INC

$163.2M
STOK

STOKE THERAPEUTICS INC

$155.1M
GHRS

GH RESEARCH PLC

$151.3M
CGEM

CULLINAN THERAPEUTICS INC

$137.6M